BCOR-CCNB3 fusion–positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up - Scorecard - MDSpire
Advertisement
BCOR-CCNB3 fusion–positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up
Clinical Scorecard: Management of BCOR-CCNB3 Fusion-Positive Sarcoma with Chemotherapy and Carbon-Ion Radiotherapy: A Case Study Highlighting Long-Term Disease Control in a Cervical Spine Patient Over 12 Years
At a Glance
Category
Detail
Condition
BCOR–CCNB3 fusion-positive sarcoma (BCS)
Key Mechanisms
Characterized by BCOR–CCNB3 gene fusion resulting from a paracentric inversion on chromosome X.
Target Population
Predominantly children and adolescents.
Care Setting
Multimodal approach including chemotherapy and radiotherapy.
Key Highlights
Initial treatment followed protocols for Ewing sarcoma.
Systemic chemotherapy resulted in tumor shrinkage.
Carbon-ion radiotherapy (CIRT) achieved durable local control.
Patient remained asymptomatic without neurological deficits over 12 years.